GlassScriptPhysician profile
Valdet Nikci
NPI 1578855235
$11,324.99
in general payments reported to CMS, 2019-2025
19 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,000 · 2020: $1,307 · 2021: $1,577 · 2022: $3,490 · 2023: $3,601 · 2024: $241 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,500 · Food and Beverage: $972 · Travel and Lodging: $479.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,500.00 |
| Food and Beverage | $971.91 |
| Travel and Lodging | $478.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $5,374.90 | 2022-2023 | |
| Gotham Surgical Solutions & Devices, INC. | $2,852.28 | 2020-2025 | |
| Axogen | $955.62 | 2019-2022 | |
| Sonex Health, INC. | $806.90 | 2022-2023 | Sx-One Microknife |
| Stryker Corporation | $360.02 | 2021-2024 | Mako, Gamma |
| Horizon Therapeutics Plc | $180.37 | 2020-2022 | |
| Endo Pharmaceuticals INC. | $153.29 | 2020-2024 | Xiaflex |
| Boston Scientific Corporation | $123.36 | 2019 | |
| Endo USA, INC. | $99.33 | 2024-2025 | Xiaflex |
| Smith+Nephew, INC. | $91.14 | 2020-2022 | |
| Acell, INC. | $64.54 | 2020 | |
| Organogenesis INC. | $42.67 | 2022 | |
| Treace Medical Concepts, INC. | $42.64 | 2025 | |
| Ibsa Pharma INC. | $40.15 | 2021-2022 | |
| Depuy Synthes Sales INC. | $39.77 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $31.01 | 2023 | Senza |
| Medtronic, INC. | $27.12 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $24.55 | 2024 | Zilretta, Iovera, Exparel |
| Globus Medical, INC. | $15.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Valdet Nikci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.